Last reviewed · How we verify

NCT06562595

What is the Optimal Training Model for Cervical Awareness?

Completed NA Last updated 20 May 2025
What this trial tests

NA trial testing Education Intervention in HPV Infection in 400 participants. Completed in 30 September 2024.

Timeline
15 August 2024
Primary endpoint
15 September 2024
30 September 2024

Quick facts

Lead sponsorIzmir City Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment400
Start date15 August 2024
Primary completion15 September 2024
Estimated completion30 September 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir City Hospital

Who can join

18 and older, female only, with HPV Infection or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cervical cancer represents the fourth most prevalent malignant disease and the fourth leading cause of mortality among women on a global scale. Despite screening and preventive vaccination efforts, cervical cancer remains a significant cause of morbidity and mortality in low- and middle-income countries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Education Intervention

Trials testing the same drug.

Other recruiting trials for HPV Infection

Currently open trials in the same condition.

Other Izmir City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06562595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing